UnknownNot Applicable

Influence of Mandibular Nerve Lateralization on Nutrition and Speech

Turkey (Türkiye)20 participantsStarted 2023-02-01

Plain-language summary

This study aimed to evaluate the effects of lip numbness on the nutritional status and speech of patients who underwent inferior nerve lateralization for dental implant placement in the mandibular posterior region. For this purpose, observational follow-up of two groups of patients will be performed. The control group will include patients with standard implant placement in the mandibular posterior region. The test group will consist of patients with implant placement in the mandibular posterior region with inferior alveolar nerve lateralization. The patients will be evaluated before implant surgery and followed up for four months until the final prosthesis is placed. Changes in nutritional status, masticatory performance and speech abilities will be assessed during this process.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * A standard dental implant with or without lateralization of the inferior alveolar nerve in the posterior region of the mandible at the Marmara University Faculty of Dentistry, Department of Oral, Dental and Maxillofacial Surgery clinic. * The patient accepted to participate in the study and gave written/verbal consent Exclusion Criteria: * Dental implant placement in the posterior region of the mandible with additional surgical methods (onlay/inlay graft, directed tissue regeneration, etc.) other than nerve lateralization. * Patients had a neurosensory disorder in the maxillofacial region before implant surgery

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change from baseline in a neurosensory disturbance with a two-point discrimination test

Timeframe: Baseline function evaluation, followed by reevaluations at 7th days, 2, 3 months.

Change from baseline in lip sensitivity pattern with semmes-weinstein monofilament test

Timeframe: Baseline function evaluation, followed by reevaluations at 7th days, 2, 3 months.

Change from baseline in nutritional status

Timeframe: Baseline evaluation, followed by reevaluations at 7th days, 2, 3 months.

Change in acoustic characteristics of speech

Timeframe: Baseline evaluation, followed by reevaluations at 7th days, 2, 3 months.

Trial details

NCT IDNCT05659069

SponsorMarmara University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-02-01

View on ClinicalTrials.gov More Alveolar Bone Loss trials

Plain-language summary

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change from baseline in a neurosensory disturbance with a two-point discrimination test

Timeframe: Baseline function evaluation, followed by reevaluations at 7th days, 2, 3 months.

Change from baseline in lip sensitivity pattern with semmes-weinstein monofilament test

Timeframe: Baseline function evaluation, followed by reevaluations at 7th days, 2, 3 months.

Change from baseline in nutritional status

Timeframe: Baseline evaluation, followed by reevaluations at 7th days, 2, 3 months.

Change in acoustic characteristics of speech

Timeframe: Baseline evaluation, followed by reevaluations at 7th days, 2, 3 months.